CERS2 antisense RNA 1 (CERS2-AS1)

CERS2-AS1 (CERS2 antisense RNA 1) is a long non-coding RNA gene located antisense to the CERS2 gene. It is transcribed as RNA but does not encode a protein and has not, as of now, been described as a therapeutic target, biomarker, or molecule with an established molecular function or disease association in the biomedical literature or major curated databases[3]. Its potential regulatory or pathophysiological functions remain to be determined. Key clarifications: CERS2-AS1 is distinct from CERS2, the gene encoding ceramide synthase 2, which is an enzyme and does have established roles in ceramide metabolism, cancer, cardiovascular, and metabolic diseases[1][5][7]. CERS2-AS1, being an antisense RNA, might regulate CERS2 but such a role has not been conclusively documented. No evidence supports CERS2-AS1 as a direct target for drugs, nor have any safety or biomarker uses been proposed. Summary: CERS2-AS1 is a long non-coding RNA gene with no current evidence of therapeutic target relevance, disease association, or clinical application[3].

None known